Understanding Your Liver Cancer Diagnosis
Clear, Supportive Insight Into Your Pathology Findings
Liver cancer begins in the liver cells and may vary by tumor type, grade, and extent of spread. Your pathology report outlines these details clearly, helping you and your care team make informed decisions about treatment and ongoing care.
HONEST Pathology specialists carefully review each part of your liver cancer report, providing clear explanations and compassionate guidance. We help you understand what every finding means so you feel confident and prepared to move forward with your diagnosis and treatment plan.
Informed Decisions
Better Conversations
Leave Empowered
Ready to Understand Your Diagnosis?
Don’t let confusion hold you back. Schedule an online consultation with our expert pathologists and get clear, personalized answers about your diagnosis — all from the comfort of home.
Frequently Asked Questions
It provides details on tumor type, grade, size, margin status, and whether cancer has spread to nearby liver tissue or lymph nodes. Biomarker or molecular testing results may also be included to guide treatment.
The most common type is hepatocellular carcinoma, which develops from liver cells. Other types include cholangiocarcinoma and mixed tumors, which require specialized evaluation.
Tumor grade describes how abnormal the cancer cells appear under a microscope. Higher-grade tumors tend to grow and spread more aggressively than lower-grade tumors.
Margin status shows whether cancer cells are present at the edge of removed tissue. Clear margins indicate complete removal, while positive margins may require additional therapy.
Pathology evaluation of nearby lymph nodes determines if the cancer has spread beyond the liver. Lymph node status is critical for accurate staging and treatment planning.
Yes. Testing for markers such as AFP, PD-L1, or other molecular targets can guide the use of targeted therapy or immunotherapy, offering a personalized treatment approach.
A second opinion is recommended for complex or rare tumor subtypes, or before major treatment decisions, to ensure diagnostic accuracy and confidence in the treatment plan.
Pathology findings help determine whether surgery, ablation, chemotherapy, targeted therapy, or immunotherapy is most appropriate based on tumor type, stage, and biological characteristics.
